This paper is only available as a PDF. To read, Please Download here.
Abstract
Post-partum hemorrhage (PPH) accounts for a substantial fraction of maternal deaths
in the general population. Among all women, however, those affected with rare bleeding
disorders (RBDs) represent a particular group since to usual bleeding symptoms, they
are likely to experience bleedings associated to obstetrical and gynaecological problems.
Pregnancy and childbirth, two important stages in the life of a woman, pose a special
clinical challenge in women with RBDs, since information about these issues are really
scarce and limited to few case reports. These data show that all women with RBDs,
except for FXI deficiency, have to be considered potentially at risk for developing
PPH, therefore they should be monitored carefully during and immediately after pregnancy.
The implication is that women with bleeding disorders may require prophylaxis and/or
close observation for several weeks and should be followed by a multidisciplinary
team including expertises such as laboratory haematologist, obstetrician-gynaecologist,
anaesthesiologist, family physician, and laboratory technician.
Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Thrombosis ResearchAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Placental and fetal physiology.in: Gabbe S Niebyl J Simpson J Obstetrics: normal and problem pregnancies. Churchill Livingstone, New York2002: 37-62
- Williams Obstetrics. 21st edn. McGraw-Hill, New York2001
- Analysis of 348 consecutive cases of primary postpartum haemorrhage in a tertiary hospital in Nigeria.J Obstet Gynecol. 2003; 23: 374-377
- Postpartum haemorrhage in nulliparous women: incidence and risk factors in low and high risk women A Dutch population-based cohort study based on standard (>500 mL) and severe (>1000 mL) postpartum haemorrhage.Eur J Obstet Gynecol Reprod Biol. 2004; 115: 166-172
- Pregnancy-related mortality surveillance – United States, 1991-1999.MMWR Surveill Summ. 2003; 52: 1-8
Health Canada. Special Report on Maternal Mortality and Severe Morbidity in Canada Enhanced Surveillance: The Path to Prevention, Ottawa, Canada: Minister of Public Works and Government Services Canada, 2004. accessed 20 September 2010.
- Trends in postpartum hemorrhage.Aust N Z J Public Health. 2006; 30: 151-156
- Trends in postpartum hemorrhage in high resource countries: a review and recommendations from the International Postpartum Hemorrhage Collaborative Group.BMC Pregnancy and Childbirth. 2009; 9: 55-65
- Recessively inherited coagulation disorders.Blood. 2004; 104: 1243-1252
- Introduction: rare bleeding disorders: general aspects of clinical features, diagnosis, and management.Semin Thromb Hemost. 2009; 35: 349-355
- European Registry of Rare Bleeding Disorders.Hematology Education: the education programme for the annual congress of the European Hematology Association. 2010; 4: 43
- More than menorrhagia: a review of the obstetric and gynaecological manifestations of bleeding disorders.Haemophilia. 2005 Jul; 11: 295-307
- Haemostasis in normal pregnancy.Thromb Haemost. 1984; 52: 176-182
- Haemostatic changes in pregnancy.Best Pract Res Clin Haematol. 2003; 16: 153-168
- Reassessment of von Willebrand factor (VWF), VWF propeptide, factor VIII:C and plasminogen activator inhibitors 1 and 2 during normal pregnancy.Br J Haematol. 2003; 121: 897-903
- Familial dysfibrinogenemia and thrombophilia. Report on a study of the SSC Subcommittee on Fibrinogen.Thromb Haemost. 1995; 73: 151-161
- Congenital hypofibrinogenemia in pregnancy.Obstet Gynecol Surv. 1989; 44: 157-161
- Factor V deficiency in pregnancy complicated by Rh immunization and placenta previa. A case report and review of the literature.Acta Obstet Gynecol Scand. 1997; 76: 890-892
- Factor VII deficiency detected in pregnancy: a case report.Am J Perinatol. 1999; 16: 223-226
- Severe factor X deficiency in pregnancy: case report and review of the literature.Haemophilia. 2004; 10: 665-668
- Pregnancies in a patient with congenital absence of prothrombin activity: case report.Am J Perinatol. 1997; 14: 135-138
- Rare coagulation disorders.Thromb Haemost. 1999; 82: 1207-1214
- Plasma replacement therapy during labor is not mandatory for women with severe factor XI deficiency.Blood Coagul Fibrinolysis. 2005; 16: 37-41
- Congenital blood coagulation factor XIII deficiency and perinatal management.Curr Drug Targets. 2005; 6: 541-549
- A survey of women's experiences of vaginal loss from 24 hours to three months after childbirth (the BLiPP Study).Midwifery. 1999; 15: 72-81
- The duration and character of postpartum bleeding among breast-feeding women.Obstet Gynecol. 1997; 89: 159-163
- Changes in blood coagulation and fibrinolysis in the normal puerperium.Gynecol Obstet Invest. 1985; 20: 37-44
- Two consecutive pregnancies and deliveries in a patient with von Willebrand's disease type 3.Haemophilia. 1998; 4: 845-849
- Post-partum haemorrhage: definitions, medical and surgical management. A time for change.Br Med Bull. 2003; 67: 205-217
- Gynaecological and obstetric management of women with inherited bleeding disorders.Int J Gynaecol Obstet. 2006; 95: 75-87
- Pregnancy and rare bleeding disorders.Haemophilia. 2009; 15: 990-1005
Article info
Identification
Copyright
© 2011 Elsevier Ltd. Published by Elsevier Inc. All rights reserved.
